Showing results (81-90 of 254) with videos related to
Sort By:
Pageof 26
Journal of the American Academy of Dermatology|November 13, 2007
Alefacept revisited: Our 3-year clinical experience in 200 patients with chronic plaque psoriasisAmy Perlmutter, Jennifer Cather, Billy Franks, et al.Expert Opinion on Emerging Drugs|November 27, 2013
Emerging topical treatments for psoriasisDario N Kivelevitch, Katherine R Hebeler, Mahir Patel, et al.Clinical Pharmacology and Therapeutics|September 30, 2017
Anti-IL-23 and Anti-IL-17 Biologic Agents for the Treatment of Immune-Mediated Inflammatory ConditionsJillian Frieder, Dario Kivelevitch, Isabel Haugh, et al.Dermatology and Therapy|June 7, 2022
Narrative Review of the Emerging Therapeutic Role of Brodalumab in Difficult-to-Treat PsoriasisAlan Menter, Tina Bhutani, Benjamin Ehst, et al.Journal of Drugs in Dermatology : JDD|April 7, 2022
Long-Term Skin Clearance With Brodalumab in Patients With Psoriasis and Inadequate Response to Prior BiologicsMark Lebwohl, Alan Menter, Edward Lain, et al.Journal of Drugs in Dermatology : JDD|May 3, 2011
Infliximab treatment for psoriasis in 120 patients on therapy for a minimum of one year: a reviewQurat Ul Ain Kamili, Andrew Miner, Asli Hapa, et al.Expert Review of Clinical Immunology|November 8, 2017
The impact of biologic agents on health-related quality of life outcomes in patients with psoriasisJillian Frieder, Dario Kivelevitch, Connie Tran Fiore, et al.Dermatology and Therapy|June 14, 2020
Brodalumab to the Rescue: Efficacy and Safety of Brodalumab in Patients with Psoriasis and Prior Exposure or Inadequate Response to BiologicsAlan Menter, April Armstrong, Abby Van Voorhees, et al.Proceedings (Baylor University. Medical Center)|June 16, 2018
Histiocytoid Sweet syndrome successfully treated with etanerceptIan T Watson, Isabel Haugh, Alexis R Gardner, et al.International Journal of Dermatology|April 17, 2008
Combining systemic retinoids with biologic agents for moderate to severe psoriasisElizabeth C A Smith, Christy Riddle, M Alan Menter, et al.Pageof 26